Correlation Between Taigen Biopharmaceutica and Tecom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Taigen Biopharmaceutica and Tecom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taigen Biopharmaceutica and Tecom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taigen Biopharmaceuticals Holdings and Tecom Co, you can compare the effects of market volatilities on Taigen Biopharmaceutica and Tecom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taigen Biopharmaceutica with a short position of Tecom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taigen Biopharmaceutica and Tecom.

Diversification Opportunities for Taigen Biopharmaceutica and Tecom

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Taigen and Tecom is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Taigen Biopharmaceuticals Hold and Tecom Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tecom and Taigen Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taigen Biopharmaceuticals Holdings are associated (or correlated) with Tecom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tecom has no effect on the direction of Taigen Biopharmaceutica i.e., Taigen Biopharmaceutica and Tecom go up and down completely randomly.

Pair Corralation between Taigen Biopharmaceutica and Tecom

Assuming the 90 days trading horizon Taigen Biopharmaceuticals Holdings is expected to under-perform the Tecom. But the stock apears to be less risky and, when comparing its historical volatility, Taigen Biopharmaceuticals Holdings is 2.16 times less risky than Tecom. The stock trades about -0.2 of its potential returns per unit of risk. The Tecom Co is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  1,375  in Tecom Co on September 1, 2024 and sell it today you would earn a total of  160.00  from holding Tecom Co or generate 11.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Taigen Biopharmaceuticals Hold  vs.  Tecom Co

 Performance 
       Timeline  
Taigen Biopharmaceutica 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Taigen Biopharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Tecom 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tecom Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Tecom is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Taigen Biopharmaceutica and Tecom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Taigen Biopharmaceutica and Tecom

The main advantage of trading using opposite Taigen Biopharmaceutica and Tecom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taigen Biopharmaceutica position performs unexpectedly, Tecom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tecom will offset losses from the drop in Tecom's long position.
The idea behind Taigen Biopharmaceuticals Holdings and Tecom Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device